Tuesday, November 17, 2015
Print Current Session:
|
|
Tuesday
SESSION 20:
ENDOVASCULAR INTERVENTIONS AND PHARMACOLOGIC REGIMENS FOR ACUTE LOWER EXTREMITY DVT: NEW EVIDENCE FOR CLINICAL SAFETY AND EFFECTIVENESS
Moderators:Thomas W. Wakefield, MD / Mark J. Garcia, MD
|
|
SESSION 20 SCHEDULE | |
2:00 PM - 2:05 PM | ATTRACT Study Of rt-PA For Acute DVT: Almost 7 Years And Almost 700 Patients, Almost Done: What Will We Find |
Presenter(s):Anthony J. Comerota, MD, FACS, FACC | |
View Slides in PDF | |
2:06 PM - 2:11 PM | Acute DVT Should Be Managed With An Aggressive Interventional Approach: Large Experience From South Asia |
Presenter(s):Narendra N. Khanna, MD, DM, FRCP, FACC | |
View Slides in PDF | |
2:12 PM - 2:17 PM | Thrombolysis For DVT: Predictors Of Success |
Presenter(s):Rabih A. Chaer, MD | |
View Slides in PDF | |
2:18 PM - 2:22 PM | BERNUTIFUL: A Beautifully Designed Trial To Evaluate Ultrasound-Assisted Thrombolysis For DVT |
Presenter(s):Nils Kucher, MD / Iris Baumgartner, MD | |
View Slides in PDF | |
2:23 PM - 2:28 PM | How Long To Anticoagulate After DVT: Duplex Imaging Guides Treatment Duration |
Presenter(s):Timothy K. Liem, MD, MBA | |
View Slides in PDF | |
2:29 PM - 2:34 PM | Understanding The Genetics Of Warfarin Dosing And Implications For Safer Anticoagulant Therapy |
Presenter(s):Karthikeshwar Kasirajan, MD | |
View Slides in PDF | |
2:35 PM - 2:40 PM | New Oral Anticoagulants For Extending Treatment Of DVT: Do They Alter The Risk/Benefit Ratio |
Presenter(s):Anthony J. Comerota, MD, FACS, FACC | |
View Slides in PDF | |
2:41 PM - 2:50 PM | Panel Discussion |
2:51 PM - 3:15 PM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 20 | |
previous | next |